UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063434
Receipt number R000072604
Scientific Title An exploratory study to investigate the effects of research food intake on skin function
Date of disclosure of the study information 2026/11/17
Last modified on 2026/10/27 19:37:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study to investigate the effects of research food intake on skin function

Acronym

An exploratory study to investigate the effects of research food intake on skin function

Scientific Title

An exploratory study to investigate the effects of research food intake on skin function

Scientific Title:Acronym

An exploratory study to investigate the effects of research food intake on skin function

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects on skin function and safety of continuous intake of the research food for 12 weeks.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin elasticity, stratum corneum hydration, transepidermal water loss

Key secondary outcomes

VISIA image analysis, wrinkle grading, wrinkle analysis, stratum corneum analysis, tissue blood flow, gut microbiota analysis, subjective questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

The test food is consumed once daily, 3 capsules per day for 12 weeks.

Interventions/Control_2

The control food is consumed once daily, 3 capsules per day for 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

65 years-old >

Gender

Female

Key inclusion criteria

(1) Healthy female aged 30 to under 65 years at the time of informed consent.
(2) Subjects who are aware of skin dryness and associated visible changes.
(3) Subjects who fully understand the purpose and content of the study and voluntarily provide written informed consent to participate.

Key exclusion criteria

(1) Subjects who regularly consume foods rich in lactic acid bacteria or bifidobacteria, or foods/supplements claiming skin or intestinal benefits.
(2) Subjects who have undergone cosmetic medical procedures affecting the measurement sites.
(3) Subjects who have undergone treatments on the measurement sites within 1 month prior to screening, or plan to do so during the study.
(4) Subjects with skin conditions affecting measurements on the measurement sites.
(5) Subjects planning severe sunburn from outdoor activities.
(6) Subjects who took antibiotics within 1 month, or regularly use drugs affecting bowel habits.
(7) Subjects with persistent diarrhea, severe constipation, or chronic gastrointestinal diseases.
(8) Subjects with serious diseases or disorders affecting sex hormone secretion.
(9) Subjects with potential allergies related to the study.
(10) Subjects requiring continuous medication or currently undergoing medical treatment.
(11) Current smokers.
(12) Excessive alcohol consumers.
(13) Shift workers or night-shift workers with irregular lifestyles.
(14) Subjects planning overseas travel during the study period.
(15) Subjects with clinically significant abnormal laboratory values at screening.
(16) Subjects who participated in other clinical trials within 1 month.
(17) Pregnant or lactating women, or those planning pregnancy.
(18) Subjects judged unsuitable based on the lifestyle questionnaire.
(19) Subjects otherwise judged unsuitable by the principal investigator.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Masaya
Middle name
Last name Miyoshi

Organization

MEGMILK SNOW BRAND Co., Ltd.

Division name

Milk Science Research Institute

Zip code

350-1165

Address

1-1-2 Minamidai, Kawagoe-shi, Saitama

TEL

080-3722-8339

Email

m-miyoshi@meg-snow.com


Public contact

Name of contact person

1st name Keiji
Middle name
Last name Yamamoto

Organization

EP-Data Weave Co., Ltd.

Division name

Food Development Business Department

Zip code

162-0814

Address

Acropolis TOKYO, 6-29 Shin-ogawamachi, Shinjuku-ku, Tokyo

TEL

070-3023-8214

Homepage URL


Email

yamamoto.keiji799@eps.co.jp


Sponsor or person

Institute

EP-Data Weave Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

MEGMILK SNOW BRAND Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Station Clinic Research Ethics Committee

Address

3-12-8, Takaban, Meguro-ku, Tokyo

Tel

03-6452-2712

Email

epmd_fd-erb@eps.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

恵比寿レイクリニック (Ebisu Ray Clinic) (東京都)


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 10 Month 14 Day

Date of IRB

2026 Year 10 Month 14 Day

Anticipated trial start date

2026 Year 11 Month 18 Day

Last follow-up date

2027 Year 03 Month 16 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 10 Month 27 Day

Last modified on

2026 Year 10 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072604